methyl 4-iodo-1H-indole-2-carboxylate

Catalog No.: 
ACVMUX549
CAS No.: 
1934418-77-5
Molecular Formula: 
C10H8INO2
Molecular Weight: 
301.08
methyl 4-iodo-1H-indole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$193.00InquiryInquiry
1g95%$590.00InquiryInquiry
5g95%$2921.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl 4-iodo-1H-indole-2-carboxylate
IUPAC Namemethyl 4-iodo-1H-indole-2-carboxylate
MDL No.0
Molecular FormulaC10H8INO2
Molecular Weight301.08
SMILESCOC(=O)C1=CC2=C(C=CC=C2I)N1
InChI KeyQJJKBLGPGQTMQO-UHFFFAOYSA-N
Synonymmethyl 4-iodo-1H-indole-2-carboxylate;1H-Indole-2-carboxylic acid, 4-iodo-, methyl ester;Methyl 4-Iodoindole-2-carboxylate
CAS No.1934418-77-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVMUX549 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMUX549 route product structure diagram
    ACVMUX5491934418-77-5
Inquiry

2. ACVMUX549 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMUX549 route product structure diagram
    ACVMUX5491934418-77-5
Inquiry

3. ACVMUX549 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVMUX549 route product structure diagram
    ACVMUX5491934418-77-5
Inquiry

Comments (0)